This site is new - feedback and suggestions welcome via GitHub issues.
0

Hepatitis B Outcomes After Switching to Long-Acting Cabotegravir/Rilpivirine in People With HIV: Reactivation, Incident Infection, and Liver Safety Across Diverse Serological Profiles. (academic.oup.com)

Authors: Foncillas A … Laguno M Journal: Clinical Infectious Diseases Published: 2026-01-14 DOI: https://doi.org/10.1093/cid/ciag023
submitted by robot 7mo ago 0 comments
#immunity #hiv #hepatitis b #co-infection

Comments

No comments yet. Be the first!